Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help

258 results

  1. Nutritional interventions in dry age-related macular degeneration - Treatments for dry age-related macular degeneration ... 
    https://www.ncbi.nlm.nih.gov/books/NBK500492
    ... replaced by lutein and zeaxanthin. Other studies of lutein and zeaxanthin supplements Quantity and quality of research ... often by provision of the supplement only. Results Lutein versus placebo or no active comparison Seven studies ...
  2. Age-related macular degeneration 
    https://medlineplus.gov/ency/article/001000.htm
    ... high amount of two natural colors (pigments) called lutein and zeaxanthin. AMD is caused by damage to ... a family history and risk factors for AMD. Lutein and zeaxanthin, which are substances found in green ...
  3. NLM Digital Collections - Index-catalogue of the Library of the Surgeon General's Office, United States Army (Series 4, ... 
    Publication: Washington : U.S. G.P.O., 1936-1948
    resource.nlm.nih.gov/8104688X10
    ... Blocage d'hemorragies uterines fonctionnelles par injection de luteins ou de benzoate de folliculine; notion de troubles ... ostet., 1939, 41: 289-303.—Chaikovsky, V. K. [Lutein in treatment of metropathia hemorrhagica] Vrach. delo, 1934, ...
  4. NLM Digital Collections - Obstetrics : a text-book for the use of students and practitioners 
    Publication: New York : Appleton, 1915
    resource.nlm.nih.gov/101164804
    ... a yellowish pigment. These cells are designated as lutein cells and, as will be seen later, play ... markedly accentuated by the pressure exerted by the lutein cells developing about its periphery. Clark, however, has ...
  5. Risk factors - Age-related macular degeneration - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536467
    ... 1,807 people). 6.2.3.4.2. Lutein/zeaxanthin supplement Moderate-quality evidence with 5 years’ follow-up could not detect a difference between lutein/zeaxanthin supplements and other supplement formulations (including beta- ...
  6. NLM Digital Collections - Index-catalogue of the Library of the Surgeon-General's Office, United States Army. Authors ... 
    Publication: Washington : G.P.O., 1880-1932
    resource.nlm.nih.gov/8104689X4
    ... eu meme temps, uue tu- meur fibreuse- tie luteins. Ibid., 1847, xxii, 292.—I^e- ger. Dilatation ...
  7. Nonsyndromic Retinitis Pigmentosa Overview - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK1417
    ... with high DHA intake [ Berson et al 2012 ]. Lutein One study of oral supplementation with 20 mg/d lutein for six months demonstrated increased macular pigment in ...
  8. Usher Syndrome Type I - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK1265
    ... women) may be teratogenic to the developing fetus. Lutein supplements may enhance retinal macular pigment. Lutein, zeaxanthin, meso-zeaxanthin, and their oxidative metabolites accumulate ...
  9. Usher Syndrome Type II - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK1341
    ... women) may be teratogenic to the developing fetus. Lutein supplements may enhance retinal macular pigment. Lutein, zeaxanthin, meso-zeaxanthin, and their oxidative metabolites accumulate ...
  10. NLM Digital Collections - Index-catalogue of the Library of the Surgeon-General's Office, United States Army. Authors ... 
    Publication: Washington : G.P.O., 1880-1932
    resource.nlm.nih.gov/8104689X10
    ... xviii, 239 — Godart. [Phthisis; tu- meurs fibrenses dc luteins ; cancer de la v6sicule biliaire et du pancreas.) ... Staatsarznk., Erlang., 1870, n. F., xxviii, 36-48.—Lutein. Pyatiustnik. Pentastoma denticulatum, lingulata. Med. pfibav. k morsk. ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last